---
id: 4
name: "Federico Weill"
company: "TxPipe"
category: "Biochemistry & Web3 Infrastructure"
location: "Argentina"
experience: "Biochemist PhD & Co-founder"
expertise:
  - "Biochemistry & Immunology"
  - "Web3 Infrastructure Development"
  - "Data Science & Software Development"
  - "Blockchain Services & Tools"
  - "Scientific Research & Innovation"
  - "Food Industry Consulting"
socialLinks:
  linkedin: "https://www.linkedin.com/in/federico-weill-84b0281b/"
  twitter: "https://x.com/FedeWeill"
  website: "https://txpipe.io/"
profileImage: "federico-weill.jpg"
bioEs: "**Federico Weill** es bioquímico con doctorado en Inmunología y una destacada trayectoria en la intersección entre ciencia, tecnología e innovación descentralizada. Durante su investigación doctoral, descubrió una molécula derivada de probióticos capaz de reducir los efectos nocivos de la radiación solar en el cáncer de piel (PubMed). Paralelamente, trabajó por más de 15 años como consultor e investigador en la industria alimentaria. En la última década, Federico se ha especializado en ciencia de datos y desarrollo de software a través de la empresa Line64. Esta combinación entre conocimiento científico y habilidades técnicas lo llevó a cofundar **Mizu/Clood**, una compañía que integraba ciencia y tecnología para desarrollar alimentos funcionales y saludables, la cual fue adquirida exitosamente en 2023. Desde 2021, es cofundador de **TxPipe**, una empresa tecnológica que construye infraestructura esencial para Web3. A través de herramientas como **Demeter.run**, TxPipe impulsa la adopción del ecosistema Cardano al facilitar soluciones robustas para desarrolladores y empresas que trabajan con aplicaciones descentralizadas y servicios blockchain."
bioEn: "**Federico Weill** is a biochemist with a PhD in Immunology and a proven track record at the crossroads of science, technology, and decentralized innovation. During his PhD research, he discovered a probiotic-derived molecule that reduces the damaging effects of solar radiation on skin cancer (PubMed). In parallel, he worked for over 15 years as a consultant and researcher in the food industry. Over the past decade, Federico has focused on data science and software development through his work at Line64. This unique combination of scientific and technical skills led him to co-found **Mizu/Clood**, a company that merged science and technology to create functional, health-focused food products, which was successfully acquired in 2023. In 2021, Federico co-founded **TxPipe**, a technology company dedicated to building core infrastructure for Web3. Through tools like **Demeter.run**, TxPipe supports the Cardano ecosystem by enabling developers and enterprises to build decentralized applications and blockchain services more efficiently and securely."
---

# Federico Weill - TxPipe

Biochemist and co-founder of TxPipe, building essential Web3 infrastructure for the Cardano ecosystem.